Breaking News, Collaborations & Alliances

Bora Pharmaceuticals Partners with TaiRx

To manufacture breakthrough anticancer drug.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Bora Pharmaceutical Laboratories Inc. (Zhunan), a division of Bora Pharmaceuticals, has partnered with TaiRx, Inc., a Taiwan-based new drug development company, to manufacture a novel anticancer drug, CVM-1118.  CVM-1118 is a new small molecule chemical entity being developed by TaiRx as a potential anti-cancer agent in numerous human cancer cell lines with strong anti-cancer activity, high safety margin, and multiple mechanisms of actions in targeting cancer-specific factors. In particula...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters